Login
$WVE
$2.87 +$0.00 (0.0%) After hours

$WVE 8-K/A SEC Filings

Filed On Filing
30 Oct 2025 8-K/A: Regulation FD Disclosure; Other Events

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

19 Dec 2022 8-K/A: Regulation FD Disclosure; Other Events

53% mean exon skipping and <1% (BLQ) mean dystrophin expression six weeks after initiating biweekly multidosing

19 Aug 2020 8-K/A: Submission of Matters to a Vote of Security Holders

On August 12, 2020, Wave Life Sciences Ltd. (the “Company”) held its 2020 Annual General Meeting of Shareholders (the “Annual Meeting”). Of the 36,728,649 ordinary shares issued and outstanding and eligible to vote as of the meeting date...

16 Aug 2019 8-K/A: Submission of Matters to a Vote of Security Holders

On August 8, 2019, Wave Life Sciences Ltd. (the “Company”) held its 2019 Annual General Meeting of Shareholders (the “Annual Meeting”). Of the 34,280,578 ordinary shares issued and outstanding and eligible to vote as of the meeting date ...

17 Aug 2017 8-K/A: Submission of Matters to a Vote of Security Holders

On August 10, 2017, the Company held its Annual Meeting. Of the 27,760,214 ordinary shares issued and outstanding and eligible to vote as of the meeting date of August 10, 2017, a quorum of 25,534,687 ordinary shares, or 91.98%, of the e...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support